Genome Editing in Drug Discovery

Genome Editing in Drug Discovery is a practical guide for researchers and professionals applying genome editing techniques to drug discovery, covering history, techniques, safety, therapeutic editing, and intellectual property issues. It also provides an introduction to CRISPRi and CRISPRa, explores genome-editing applications in stem cell engineering and regenerative medicine, and discusses safety aspects and socio-economic and bioethical challenges.

Format: Hardback
Length: 352 pages
Publication date: 01 April 2022
Publisher: John Wiley & Sons Inc

In the realm of drug discovery, genome editing holds immense potential as a powerful tool for researchers and professionals to manipulate and alter the genetic makeup of cells. This innovative approach allows for the precise targeting and modification of genes, which can lead to the development of new therapies and treatments for a wide range of diseases.

Genome Editing in Drug Discovery, a comprehensive guide authored by a team of distinguished biologists, delves into the intricate world of genome editing in drug discovery. The book provides a thorough exploration of the technology's history, current issues, techniques, and future perspectives, offering valuable insights for researchers and professionals alike.

One of the key aspects covered in the book is disease modeling, which involves the creation of computer simulations and models to understand the biological mechanisms underlying diseases. Genome editing techniques, such as CRISPR-Cas9, have revolutionized disease modeling by enabling researchers to precisely edit genes and study their effects on cellular processes and disease development.

Target identification is another critical step in drug discovery, and genome editing has played a pivotal role in this process. CRISPR-Cas9 allows researchers to identify specific genes or genetic regions associated with diseases, which can then be targeted for therapeutic intervention. This approach has led to the development of new treatments for genetic disorders such as cystic fibrosis and sickle cell anemia.

Safety studies are another crucial aspect of genome editing, as the potential risks and unintended consequences of genetic manipulation must be carefully evaluated. Genome Editing in Drug Discovery provides comprehensive discussions on safety considerations, including immunogenicity and the specificity of CRISPR-Cas9 gene editing. The book offers practical suggestions for practitioners and academicians involved in drug discovery to ensure the safe and effective use of genome editing techniques.

Therapeutic editing, another application of genome editing, involves the correction of genetic defects or the introduction of new genes to treat diseases. Genome Editing in Drug Discovery explores the potential of therapeutic editing in various disease areas, including cancer, heart disease, and neurological disorders. The book discusses the challenges and opportunities associated with therapeutic editing and provides insights into the development of personalized medicine approaches.

Intellectual property issues are also a significant concern in the field of genome editing. Genome Editing in Drug Discovery addresses the complex legal and ethical considerations surrounding the patenting and commercialization of genome-edited technologies. The book provides an in-depth examination of the CRISPR-Cas9 patent landscape, highlighting the challenges and opportunities for innovators and researchers.

In addition to its technical content, Genome Editing in Drug Discovery offers practical suggestions for practitioners and academicians involved in drug discovery. The book provides a comprehensive introduction to the applications of CRISPRi and CRISPRa in drug discovery, covering topics such as drug screening, lead optimization, and preclinical testing. It also explores genome-editing applications in stem cell engineering and regenerative medicine, offering insights into the potential of these technologies for tissue repair and regeneration.

Genome Editing in Drug Discovery is a valuable resource for academic researchers and professionals in the biotech and pharmaceutical industries. The book provides a comprehensive treatment of genome editing in drug discovery, covering a wide range of topics and offering insights into the latest research and developments in the field. It will also earn a place in the libraries of medicinal chemists, biochemists, and molecular biologists, who are actively engaged in drug discovery and development.

In conclusion, genome editing holds immense potential for drug discovery and has the potential to revolutionize the way we develop new therapies and treatments for diseases. Genome Editing in Drug Discovery provides a comprehensive exploration of this innovative technology, offering valuable insights for researchers and professionals alike. As the field continues to evolve, it is clear that genome editing will play an increasingly important role in shaping the future of healthcare and medicine.

Weight: 1107g
Dimension: 279 x 216 x 21 (mm)
ISBN-13: 9781119671343